Intermittent nitrate therapy for prior myocardial infarction does not induce rebound angina nor reduce cardiac events

Internal Medicine

Volumn 39, Issue 12, 2000, Pages 1020-1026

  Ishikawa, Kinji ^a   Yamamoto, Tadahiko ^a   Kanamasa, Ken ^a   Hayashi, Takahiro ^a   Takenaka, Toshihiko ^a   Kimura, Akio ^a   Miyataka, Masaru ^a   Yabushita, Hiroshi ^a   Kitayama, Koji ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac events; Coronary vasospasm; Hypervascular response; Nitrate free interval; Secondary prevention of myocardial infarction

Indexed keywords

GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG INTERMITTENT THERAPY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; REBOUND; RETROSPECTIVE STUDY;

EID: 0034518826     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.1020     Document Type: Article

References (35)

1. Mangione NJ, Glasser SP. Phenomenon of nitrate tolerance. Am Heart J 128: 137-146, 1994.
2. Wood D. European and American recommendations for coronary heart disease prevention. Eur Heart J 19 (Suppl A): A12-A19, 1998.
3. Amsterdam EA. Rationale for intermittent nitrate therapy. Am J Cardiol 70: 55G-60G, 1992.
4. Ferratini M, Pirelli S, Merlini P, Silva P, Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: A comparison with a continuous schedule. Eur Heart J 10: 998-1002, 1989.
5. DeMots H, Glasser SP, on behalf of the Transderm-Nitro Trial Study Group. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol 13: 786-793, 1989.
6. Dickstein K, Knutsen H. A double-blind multiple crossover trial evaluating a transdermal nitroglycerin system vs placebo. Eur Heart J 6: 50-56, 1985.
7. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med 338: 520-531, 1998.
8. Parker JO, Amies MH, Hawkinson RW, et al and the Minitran Efficacy Study Group. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Circulation 91: 1368-1374, 1995.
9. Freedman SB, Daxini BV, Noyce D, Kelly DT. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: Potential role of rebound ischemia during the nitrate-free period. J Am Coll Cardiol 25: 349-355, 1995.
10. Parker JO, and the Isosorbide-5-Mononitrate Study Group. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris. Am J Cardiol 72: 871-876, 1993.
11. Chrysant SG, Glasser SP, Bittar N, et al. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol 72: 1249-1256, 1993.
12. Olsson G, Allgén J, Amtorp O, Nyberg G, Parker JO. Absence of predose rebound phenomena with once daily 5-ISMN in a controlled-release formulation. Eur Heart J 13: 814-817, 1992.
13. Scardi S, Camerini F, Pandullo C, Pollavini G, and the Collaborative Nitro Group. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: A multicentric study. Int J Cardiol 32: 241-248, 1991.
14. Münzel T, Kurz S, HeitzerT, Harrison DG. New insights into mechanisms underlying nitrate tolerance. Am J Cardiol 77: 24C-30C, 1996.
15. Thadani U, Maranda CR, Amsterdam E, et al. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med 120: 353-359, 1994.
16. Cowan JC. Avoiding nitrate tolerance. Br J Clin Pharmac 34: 96-101, 1992.
17. Ishikawa K, Kanamasa K, Ogawa I, et al on behalf of the Secondary Prevention Group. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn Circ J 60: 779-788, 1996.
18. Frishman WH. Tolerance, rebound, and time-zero effect of nitrate therapy. Am J Cardiol 70: 43G-48G, 1992.
19. Heger JJ, Weyman AE, Wann LS, Rogers EW, Dillon JC, Feigenbaum H. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction. Circulation 61: 1113-1118, 1980.
20. Wagner GS, Freye CJ, Palmeri ST, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. I. specificity and observer agreement. Circulation 65: 342-347, 1982.
21. Cowan JC, Bourke JP, Reid DS, Julian DG. Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol 60: 271-275, 1987.
22. Parker JO, Fung H-L. Transdermal nitroglycerin in angina pectoris. Am J Cardiol 54: 471-476, 1984.
23. Silber S, Vogler AC, Krause K-H, Vogel M, Theisen K. Induction and circumvention of nitrate tolerance applying different dosage intervals. Am J Med 83: 860-870, 1987.
24. Parker JD, Parker AB, Farrell B, Parker JO. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval. Circulation 91: 973-978, 1995.
25. Figueras J, Lidon R, Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest. Eur Heart J 12: 405-411, 1991.
26. Fox KM, Dargie HJ, Deanfield J, Maseri A, on behalf of the Transdermal Nitrate Investigators. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. Br Heart J 66: 151-155, 1991.
27. Schaer DH, Buff LA, Katz RJ. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am J Cardiol 61: 46-50, 1988.
28. Luke R, Sharpe N, Coxon R. Transdermal nitroglycerin in angina pectoris: Efficacy of intermittent application. J Am Coll Cardiol 10: 642-646, 1987.
29. Lange RL, Reid MS, Tresch DD, Keelan MH, Bernhard VM, Coolidge G. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 46: 666-678, 1972.
30. Reeves WC, Cook L, Wood MA, Whitesell L. Coronary artery spasm after abrupt withdrawal of nitroglycerin in rabbits. Am J Cardiol 55: 1066-1069, 1985.
31. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure. Jpn Circ J 62: 353-358, 1998.
32. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C, for the Multicenter Myocardial Ischemia Research Group. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Am Heart J 138: 577-585, 1999.
33. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343: 1115-1122, 1994.
34. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345: 669-685, 1995.
35. Teo KK, Catellier DJ. Long-term nitrate use in chronic coronary artery disease: Need for a randomized controlled trial. Am Heart J 138: 400-402, 1999.